针对肺CD11b+树突细胞的调节可缓解过敏性喘中的Th2气道炎症
Mi Cheng1, Pan-Pan Shang1, Dan-Dan Wei1
1Shanghai Research Institute of Acupuncture and Meridian,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Chinese medicine
|May 22, 2025
概括
针有效地减少过敏喘症状,通过调节肺部树突细胞 (DCs). 这项研究揭示了针如何向CD11b+DCs以缓解Th2气道炎症,提供了新的治疗见解.
科学领域:
- 免疫学 免疫学 免疫学
- 过敏和喘研究研究
- 传统中国医药 传统中国医药
背景情况:
- 过敏性喘的特征是Th2介导的呼吸道炎症,树突细胞 (DCs) 起着关键作用.
- 针调节免疫反应的潜力是公认的,但其在过敏性喘中的具体机制仍然不清楚.
- 这项研究调查了针如何影响肺CD11b+DCs以减轻Th2气道炎症.
研究的目的:
- 阐明针在过敏性喘小鼠模型中缓解Th2气道炎症的机制.
- 研究肺CD11b+树突细胞 (DCs) 在针治疗效果中的作用.
- 探索针对免疫细胞种群,细胞因子概况和过敏反应的影响.
主要方法:
- 在雌性BALB/c小鼠中建立室内灰尘虫 (HDM) 诱导的过敏喘模型.
- 在特定的针点 (大,门,费寿) 进行针治疗,并评估气道过敏反应 (AHR),免疫细胞透和组织学变化.
- 评估Th2细胞因子的产生,血清IgE水平,T细胞激活,骨髓衍生的树突细胞 (BMDC) 活动,以及CD11b+DCs通过流细胞计和采用转移的作用.
主要成果:
- 针显著降低了喘小鼠的AHR,呼吸道炎症,杯状细胞增生和血清IgE水平.
- 针调节了BMDC活动,并且,当应用于肺DC时,减少了Th2细胞的招募和改善了气道炎症.
- 针降低了肺 CD11b+ DC 种群,降低了它们的激活标志物 (CD86,OX40L) 的调节,并调节了化学激素表达 (CCL17,CCL22,CCR7,CCL2,CCL8),抑制了上皮警示素和ILC2s.
结论:
- 针可以通过调节肺CD11b+树突细胞的活动来缓解过敏性喘中的Th2气道炎症.
- 这些发现为针的免疫调节作用提供了新的见解,并支持其作为喘治疗策略的潜力.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
515
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
515
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma: Pathogenesis and Management
628
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
628
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
503
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
503


